share_log

Oppenheimer Reiterates Outperform on Zura Bio, Lowers Price Target to $16

Benzinga ·  Apr 1 21:33

Oppenheimer analyst Jeff Jones reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment